December 2024 - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Hansa Biopharma Shares Positive Imlifidase Phase II Study Data in Rare Autoimmune Disorder

December 31, 2024

Medical Device News

Boston Scientific Issues Recall for Accolade Pacemakers Linked to 2 Deaths

December 30, 2024

Clinical Trial News

Cenerimod Reduces SLE Disease Activity, Paves the Way for Phase III

December 30, 2024

New Insights into Quality Assurance Jobs: Impact, Growth and Opportunities

December 30, 2024

Gastro Concepts’ Air Assist Device: Improving Procedural Colonoscopy

December 27, 2024

Clinical Trial News

Obicetrapib Lowers LDL-C as Monotherapy and with Ezetimibe in Phase III Trials

December 26, 2024

Top 10 New Prescription Drug TV Commercials in 2024

December 24, 2024

International Day of Epidemic Preparedness 2024: Amplifying Global Resilience

December 23, 2024

Clinical Trial News

Deupirfenidone Could Perform Better Than Standard IPF Therapy

December 23, 2024

Celltrion’s Steqeyma Approved as Stelara Biosimilar for Psoriasis

December 20, 2024

Regulatory Affairs Jobs: Key Roles, Career Paths and Industry Impact

December 20, 2024

FDA Approves Ensacove (Ensartinib) for Advanced NSCLC in Crowded ALK Inhibitor Market

December 19, 2024

FDA Issues Complete Response Letter to J&J for Subcutaneous Rybrevant Filing

December 19, 2024

Psychiatry Clinical Trials: Inclusive, Patient-Centric Approaches for Mental Health Research

December 19, 2024

Neurocrine Biosciences’ Crenessity Approved as First New Treatment in Decades for Rare Genetic Disorder CAH

December 18, 2024

Unloxcyt Wins FDA Approval for Advanced Skin Cancer, Set to Compete with Keytruda

December 18, 2024

Next Page »